SCHEMBL3344702

SCHEMBL3344702

C1=CC2([Rh]C34C=CC(C=C3)C4)C=CC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6301151 0.78
SCHEMBL14954135 0.78
SCHEMBL1450032 0.61
SCHEMBL5961448 0.61
SCHEMBL1521441 0.61
SCHEMBL1521444 0.61
SCHEMBL8926696 0.61
SCHEMBL3193485 0.59
SCHEMBL11742812 0.59
SCHEMBL4450913 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140112870-A1 NMR spectroscopy and MRI methods and systems NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2014-04-24 US disclosed
US-8513234-B2 HIV integrase inhibitors MERCK SHARP & DOHME CORP. (US) 2013-08-20 US disclosed
US-20130006099-A1 COMPOSITIONS AND METHODS FOR METABOLIC IMAGING IMAGNX, INC. 2013-01-03 US disclosed
WO-2010042392-A2 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2010-04-15 WO disclosed
US-20100087419-A1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME LLC 2010-04-08 US disclosed